SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-043425
Filing Date
2017-07-05
Accepted
2017-07-05 17:47:54
Documents
1
Period of Report
2017-07-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4007
  Complete submission text file 0001209191-17-043425.txt   5420
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Issuer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARDELYX, INC. 34715 ARDENWOOD BLVD, SUITE 100 FREMONT CA 94555
Business Address
Jenkins Annalisa (Reporting) CIK: 0001639481 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37601 | Film No.: 17948739